Normand Laperriere
Overview
Explore the profile of Normand Laperriere including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
153
Citations
3592
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malmstrom A, Oppong F, O Callaghan C, Wick W, Laperriere N, Gorlia T, et al.
Neurooncol Adv
. 2025 Jan;
6(1):vdae211.
PMID: 39759261
Background: The majority of patients diagnosed with glioblastoma are >60 years. Three randomized trials addressed the roles of radiotherapy (RT) and temozolomide (TMZ) for elderly patients. NORDIC and NOA-08 compared...
2.
Lau R, Gutierrez-Valencia E, Santiago A, Lai C, Ahmed D, Habibi P, et al.
Brain Sci
. 2024 Nov;
14(11).
PMID: 39595822
Background/objectives: Around 20% of cancer patients will develop brain metastases (BrMs), with 15-25% occurring in the posterior fossa (PF). Although the effectiveness of systemic therapies is increasing, surgery followed by...
3.
Kim I, Yan M, Sourour M, Heaton R, Faulkner C, Kalyvas A, et al.
J Neurooncol
. 2024 Oct;
171(2):423-430.
PMID: 39466561
Purpose: Pituitary neuroendocrine tumors (pitNETs) are benign tumors that may recur after surgical resection or persist following medical management. The objective of this study was to evaluate outcomes and toxicities...
4.
Nag A, Krema H, Saeed Kamil Z, Akbar B, Laperriere N
Orbit
. 2024 Aug;
:1-3.
PMID: 39110017
Primary basal cell carcinoma (BCC) of the conjunctiva is a rare tumor with only six cases reported in literature. We present the case of an 81-year-old male complaining of a...
5.
Tsang D, Tsui G, Santiago A, Keller H, Purdie T, McIntosh C, et al.
Int J Radiat Oncol Biol Phys
. 2024 Mar;
119(5):1429-1436.
PMID: 38432285
Purpose: The capacity for machine learning (ML) to facilitate radiation therapy (RT) planning for primary brain tumors has not been described. We evaluated ML-assisted RT planning with regard to clinical...
6.
Ritchie T, Awrey S, Maganti M, Chahin R, Velec M, Hodgson D, et al.
Radiother Oncol
. 2024 Feb;
193:110120.
PMID: 38311029
Purpose: Children who require radiation therapy (RT) should ideally be treated awake, without anaesthesia, if possible. Audiovisual distraction is a known method to facilitate awake treatment, but its effectiveness at...
7.
Gutierrez-Valencia E, Kalyvas A, Jamora K, Yang K, Lau R, Khan B, et al.
Clin Transl Radiat Oncol
. 2024 Jan;
45:100723.
PMID: 38282910
Background: Stereotactic radiosurgery (SRS) has supplanted whole brain radiotherapy (WBRT) as standard-of-care adjuvant treatment following surgery for brain metastasis (BrM). Concomitant with the adoption of adjuvant SRS, a new pattern...
8.
Sienna J, Kahalley L, Mabbott D, Grosshans D, Santiago A, Paulino A, et al.
Int J Radiat Oncol Biol Phys
. 2023 Dec;
119(1):200-207.
PMID: 38040059
Purpose: Emerging evidence suggests proton radiation therapy may offer cognitive sparing advantages over photon radiation therapy, yet dosimetry has not been compared previously. The purpose of this study was to...
9.
Anthes V, Schwartz M, Cusimano M, Radovanovic I, Kulkarni A, Laperriere N, et al.
Neurosurgery
. 2023 Oct;
94(3):575-583.
PMID: 37796152
Background And Objectives: Stereotactic radiosurgery (SRS) marginal dose is associated with successful obliteration of cerebral arteriovenous malformations (AVM). SRS dose rate-how old the cobalt-60 sources are-is known to influence outcomes...
10.
Yang K, Begley S, Lynch D, Ye V, Saini J, Gutierrez E, et al.
Pituitary
. 2023 Sep;
26(5):538-550.
PMID: 37698666
Purpose: To understand the natural history and optimal treatment strategy for pituitary gland metastasis. Methods: We performed both a retrospective chart review of patients treated at our institution and a...